- Report
- January 2026
- 378 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 467 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 174 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 373 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 285 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 487 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 471 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 468 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 170 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 374 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 194 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 473 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 373 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 370 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 186 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 269 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 277 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 281 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more